de Godoy Jose Maria Pereira, de Godoy Henrique Jose Pereira, Guimarães Tania Dias, Godoy Maria de Fatima Guerreiro
Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto School of Medicine (FAMERP), CNPq (National Council for Research and Development), Sao Jose do Rio Preto, Brazil.
Physician, Medical Degree from Universidade Federal do Mato Grosso-Cuiabá-UFMT and Member Clínica Godoy Research Group, Sao Jose do Rio Preto, Brazil.
Int J Health Sci (Qassim). 2021 Sep-Oct;15(5):42-45.
Chest pain and swelling are routinely reported in women after breast cancer treatment and are often not valued by health professionals. In general, these patients suffer and without many effective solutions. The aim of the present study was to report the results of a novel technique for the treatment of chest pain related to breast cancer treatment.
A clinical trial was conducted involving 25 women with chest pain resulting from the treatment of breast cancer and submitted to treatment for lymphedema at the Godoy School in 2018. Godoy's intermittent dermal therapy was performed on the participants 2-4 h/day for 2 days until the occurrence of a significant improvement or complete resolution of pain (measured using the visual analog pain scale).
All patients reported a significant reduction in pain in the first ½ h of treatment ( < 0.0001, Wilcoxon signed-rank test). Six of the 25 patients (24%) reported the absence of pain after treatment on the 1 day and all (100%) reported the absence of pain at the end of treatment on the 2 day.
Chronic chest pain in patients having been submitted to treatment for breast cancer can be significantly reduced with Godoy's intermittent skin therapy, achieving standards of normality or near normality within only a few sessions.
胸痛和肿胀是乳腺癌治疗后女性患者常报告的症状，且往往未得到医护人员的重视。总体而言，这些患者承受着痛苦且没有太多有效的解决办法。本研究的目的是报告一种治疗与乳腺癌治疗相关胸痛的新技术的结果。
进行了一项临床试验，纳入25例因乳腺癌治疗导致胸痛且于2018年在戈多伊学校接受淋巴水肿治疗的女性。对参与者进行戈多伊间歇性皮肤治疗，每天2 - 4小时，持续2天，直至疼痛显著改善或完全缓解（使用视觉模拟疼痛量表测量）。
所有患者在治疗的前半小时均报告疼痛显著减轻（Wilcoxon符号秩检验，P < 0.0001）。25例患者中有6例（24%）在治疗第1天结束后报告疼痛消失，所有患者（100%）在治疗第2天结束时报告疼痛消失。
接受乳腺癌治疗的患者的慢性胸痛可通过戈多伊间歇性皮肤治疗显著减轻，仅需几次治疗就能达到正常或接近正常水平。
